These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26105103)

  • 21. Observational study of alternative therapies among paediatric emergency department patients.
    Ding JL; Taylor DM; Lee M; Johnson OG; Ashok A; Griffiths M; Simma L; Craig SS; Cheek JA; Babl FE
    Emerg Med Australas; 2017 Apr; 29(2):136-142. PubMed ID: 28244266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Off-label Medication Prescribing Patterns in Pediatrics: An Update.
    Yackey K; Stukus K; Cohen D; Kline D; Zhao S; Stanley R
    Hosp Pediatr; 2019 Mar; 9(3):186-193. PubMed ID: 30745323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Off-Label and Unlicenced Medicine Use among Hospitalised Children in South Africa: Practice and Policy Implications.
    Mathevula H; Schellack N; Orubu S; Godman B; Matlala M
    Pharmacy (Basel); 2023 Nov; 11(6):. PubMed ID: 37987384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Off-label paediatric drug use in an Indonesian community setting.
    Abdulah R; Khairinisa MA; Pratiwi AA; Barliana MI; Pradipta IS; Halimah E; Diantini A; Lestari K
    J Clin Pharm Ther; 2015 Aug; 40(4):409-12. PubMed ID: 25884353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-label and off-label use of respiratory drugs in the Italian paediatric population.
    Baiardi P; Ceci A; Felisi M; Cantarutti L; Girotto S; Sturkenboom M; Baraldi E
    Acta Paediatr; 2010 Apr; 99(4):544-9. PubMed ID: 20105140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence.
    Czaja AS; Valuck R
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):997-1004. PubMed ID: 22760843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
    Dos Santos L; Heineck I
    Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-label medicine use in children and adolescents: results of a population-based study in Germany.
    Knopf H; Wolf IK; Sarganas G; Zhuang W; Rascher W; Neubert A
    BMC Public Health; 2013 Jul; 13():631. PubMed ID: 23822744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of increasing ondansetron use on clinical outcomes in children with gastroenteritis.
    Freedman SB; Hall M; Shah SS; Kharbanda AB; Aronson PL; Florin TA; Mistry RD; Macias CG; Neuman MI
    JAMA Pediatr; 2014 Apr; 168(4):321-9. PubMed ID: 24566613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children.
    Schaffer AL; Bruno C; Buckley NA; Cairns R; Litchfield M; Paget S; Zoega H; Nassar N; Pearson SA
    Paediatr Perinat Epidemiol; 2022 Sep; 36(5):726-737. PubMed ID: 35172017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Off-label prescribing for allergic diseases in pre-school children.
    Morais-Almeida M; Cabral AJ
    Allergol Immunopathol (Madr); 2014; 42(4):342-7. PubMed ID: 23769737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insufficient access to oral paediatric medicines in Ghana: A descriptive study.
    Ankrah DNA; Turkson JT; Boateng EB; Amegavie FTT; Bruce E
    BMC Health Serv Res; 2016 Jun; 16():198. PubMed ID: 27317085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
    Saiyed MM; Lalwani T; Rana D
    Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-label and unlicensed medicines to hospitalised children in Norway.
    Teigen A; Wang S; Truong BT; Bjerknes K
    J Pharm Pharmacol; 2017 Apr; 69(4):432-438. PubMed ID: 27334565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extent to which off-patent registered prescription medicines are used for off-label indications in Australia: A scoping review.
    Howe K; Bourke S; Sansom L
    PLoS One; 2021; 16(12):e0261022. PubMed ID: 34860857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pattern of poisoning cases in Emergency Department of Kathmandu Medical College Teaching Hospital.
    Thapa SR; Lama P; Karki N; Khadka SB
    Kathmandu Univ Med J (KUMJ); 2008; 6(2):209-13. PubMed ID: 18769088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Off-label drug prescriptions among outpatient children and adolescents in Germany--a database analysis].
    Sonntag D; Trebst D; Kiess W; Kapellen T; Bertsche T; Kostev K
    Dtsch Med Wochenschr; 2013 Oct; 138(44):2239-45. PubMed ID: 24150699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Off-label drug use in a single-center pediatric cardiac intensive care unit.
    Maltz LA; Klugman D; Spaeder MC; Wessel DL
    World J Pediatr Congenit Heart Surg; 2013 Jul; 4(3):262-6. PubMed ID: 24327493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Off-Label Drug Use in Ambulatory Settings: 2006-2015.
    Hoon D; Taylor MT; Kapadia P; Gerhard T; Strom BL; Horton DB
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31527173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.